tirzepatide 60mg vial dosage chart How long will you take

Low Risk of Low Blood Sugar: Unlike some other diabetes medications, Ozempic doesn't often cause dangerously low blood sugar levels, making it safer for many people

GLP-1 potentiates glucose-induced insulin secretion, inhibits glucagon secretion but also has extrapancreatic effects and inhibits appetite and food intake

Bone density considerations also come into play, as bone health during GLP-1 treatment requires adequate calcium and vitamin D intake

PMC 10166133

With dose reduction, the timeline is not well documented but would be expected to fall somewhere between discontinuation and continued use

Eissele R, Goke R, Willemer S, Harthus HP, Vermeer H, Arnold R, and Goke B